BIOVIE INC.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 13, 2026
BIVI$1.30-2.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations
| Year Ended | Year Ended | |
|---|---|---|
| June 30, 2026 | June 30, 2025 | |
| OPERATING EXPENSES: | ||
| Amortization of intangible assets | $178,341 | $229,377 |
| Research and development expenses | 13,962,360 | 9,266,734 |
| General and administrative expenses | 8,511,032 | 8,570,089 |
| TOTAL OPERATING EXPENSES | 22,651,733 | 18,066,200 |
| LOSS FROM OPERATIONS | (22,651,733) | (18,066,200) |
| OTHER (INCOME) EXPENSE: | ||
| Change in fair value of derivative liabilities | - | (3,771) |
| Interest expense | 17,901 | 332,720 |
| Interest income | (596,771) | (853,029) |
| TOTAL OTHER INCOME, NET | (578,870) | (524,080) |
| NET LOSS | $(22,072,863) | $(17,542,120) |
| Deemed dividend related to ratchet adjustment to warrants | 43,544 | 369,465 |
| NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS | $(22,116,407) | $(17,911,585) |
| NET LOSS PER COMMON SHARE | ||
| - Basic | $(3.05) | $(12.12) |
| - Diluted | $(3.05) | $(12.12) |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING | ||
| - Basic | 7,245,928 | 1,477,372 |
| - Diluted | 7,245,928 | 1,477,372 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.